Tag: steven halpern

ConocoPhillips (COP): Portfolio Anchor

Filed in Bank Gold, commodities, Conoco, earnings, HAL, o, revenue, Tegra by on February 18, 2011 0 Comments
ConocoPhillips (COP): Portfolio Anchor

Filed under: Newsletters , ConAgra Foods (CAG) , Commodities , Oil , Stocks to Buy “ConocoPhillips ( COP ) is not only my favorite integrated oil company, it is also on the short-list of my favorite stocks, period,” says Nathan Slaughter . The editor of Street Authority Market Advisor explains, “The company is raking in cash; the integrated oil giant pocketed $2.0 billion in net profits last quarter on $53.2 billion in revenues. “For all of 2010, earnings soared nearly 160% to $11.4 billion. That percentage gets cut in half when you exclude one-time gains and charges. Still, it’s a good time to be a shareholder. Continue reading ConocoPhillips (COP): Portfolio Anchor ConocoPhillips (COP): Portfolio Anchor originally appeared on BloggingStocks on Fri, 18 Feb 2011 10:00:00 EST. Please see our terms for use of feeds . Permalink  |  Email this  |  Comments

Continue Reading »

Fidelity Select Healthcare (FSPHX): The Right Prescription

Filed in Bank Gold, economy, o by on February 17, 2011 0 Comments
Fidelity Select Healthcare (FSPHX): The Right Prescription

Filed under: Newsletters , Mutual Funds “We own a healthy dose of Fidelity Select Healthcare ( FSPHX ) in each of our model portfolios,” says fund expert Jim Lowell . The editor of Fidelity Investor explains, “Manager Eddie Yoon and I caught up this month. His command of the sector and his growth-oriented discipline continue to serve us well on both our risk-adjusted and real return fronts/ “Of course, healthcare (representing nearly 16% of our total GDP) is unlike any other sector in the S&P. It is so diversified and global, so interrelated to technology, manufacturing, and R&D, so dependent upon delivering real goods and services for consumer consumption, that it is almost an economy unto itself. Continue reading Fidelity Select Healthcare (FSPHX): The Right Prescription Fidelity Select Healthcare (FSPHX): The Right Prescription originally appeared on BloggingStocks on Thu, 17 Feb 2011 13:00:00 EST. Please see our terms for use of feeds . Permalink  |  Email this  |  Comments

Continue Reading »

Royal Gold (RGLD): A Net Asset Value Buy

Filed in Bank Gold, commodities, gld, Gold, o, penasquito, Penasquito Mine, revenue, royal gold by on February 16, 2011 0 Comments

Filed under: International Markets , Newsletters , Mexico , Commodities , Stocks to Buy “Royal Gold ( RGLD ), a gold royalty operation, is progressing well, and is a good buy at current levels,” says global resources expert Adrian Day . The editor of The Global Analyst explains, “Over $6 a share income by 2013 makes Royal Gold fundamentally inexpensive; it is also selling below a reasonable net asset value, unusually for gold stocks. “The company hold a gold royalty on part of the huge Penasquito mine in Mexico, which had a good first quarter. Royal Gold has other new projects gearing up to boost revenues. Andacollo started production in October, so this year will see a full year of revenues from two new mines. Continue reading Royal Gold (RGLD): A Net Asset Value Buy Royal Gold (RGLD): A Net Asset Value Buy originally appeared on BloggingStocks on Wed, 16 Feb 2011 12:30:00 EST. Please see our terms for use of feeds . Permalink  |  Email this  |  Comments

Continue Reading »

FedEx (FDX): Still Set to Deliver?

Filed in Bank Gold, EPS, euro, Guidance, o, ubs by on February 16, 2011 0 Comments
FedEx (FDX): Still Set to Deliver?

Filed under: Newsletters , FedEx Corp (FDX) , Stocks to Buy “It’s not too often that a company lowers its guidance and the stock rises, but such is the case with FedEx ( FDX ),” says Geoffrey Seiler . The editor of BullMarket .com explains, “The company cut its fiscal Q3 guidance; but given the terrible weather, which impacted a number of airports across the U.S. and Europe, and higher fuel costs, it was largely expected. “The package delivery firm now expects to produce adjusted EPS of 70-90 cents, down from prior guidance of 95 cents to $1.15. Analysts were expecting EPS of $1.04 for the quarter. Continue reading FedEx (FDX): Still Set to Deliver? FedEx (FDX): Still Set to Deliver? originally appeared on BloggingStocks on Wed, 16 Feb 2011 10:30:00 EST. Please see our terms for use of feeds . Permalink  |  Email this  |  Comments

Continue Reading »

Quantitative System Picks ExxonMobil (XOM)

Filed in Bank Gold, commodities, ExxonMobil, o, shares by on February 10, 2011 0 Comments
Quantitative System Picks ExxonMobil (XOM)

Filed under: International Markets , Newsletters , Expedia Inc (EXPE) , Commodities , Oil , Stocks to Buy “On our proprietary Quadrix(R) rating system, ExxonMobil ( XOM ) has steadily advanced over the past year,” says Richard Moroney . The editor of Dow Theory Forecasts explains, “Out of a possible 100, the oil giant earns an Overall score of 96 — compared to just 51 in January 2010. As such, we rate the stock a long-term buy. “Meanwhile, the shares recently rallied to their highest level since January 2009 after Exxon said it earned $1.85 excluding special items in the December quarter, up 46% and $0.22 above the consensus estimate. Continue reading Quantitative System Picks ExxonMobil (XOM) Quantitative System Picks ExxonMobil (XOM) originally appeared on BloggingStocks on Thu, 10 Feb 2011 10:30:00 EST. Please see our terms for use of feeds . Permalink  |  Email this  |  Comments

Continue Reading »

Oil Services Favorites: Schlumberger, National Oilwell Varco

Filed in Bank Gold, commodities, economy, lead, o by on February 9, 2011 0 Comments
Oil Services Favorites: Schlumberger, National Oilwell Varco

Filed under: Newsletters , Schlumberger Limited (SLB) , Commodities , Oil , Stocks to Buy “Oil had a good year in 2010, rising 15 percent, and 2011 looks to be even better, as a stronger global economy pushes demand for resources higher,” says Stephen Leeb . The editor of The Complete Investor explains, “Oil service and equipment companies are the most leveraged way to play rising oil prices. Here’s a look a Schlumberger ( SLB ) and National Oilwell Varco ( NOV ). “First is Schlumberger, operating in more than 80 countries. The company is the world’s leading supplier of energy technology, project management, and information solutions. Continue reading Oil Services Favorites: Schlumberger, National Oilwell Varco Oil Services Favorites: Schlumberger, National Oilwell Varco originally appeared on BloggingStocks on Wed, 09 Feb 2011 12:40:00 EST. Please see our terms for use of feeds . Permalink  |  Email this  |  Comments

Continue Reading »

NetEase (NTES): China’s Expanding Internet

Filed in Bank Gold, o, revenue, shares, Yahoo by on February 8, 2011 0 Comments
NetEase (NTES): China’s Expanding Internet

Filed under: International Markets , China , Newsletters , Stocks to Buy “NetEase ( NTES ) fits right into the theme of rapidly expanding Internet revenues and profits in China,” says Jim Trippon . The editor of the China Stock Digest explains, “At least 450 million Chinese are now online. Online gaming has 265 million users and is expected to gross over $4 billion over the past year. “This company has a wide offering of products, even though it is mostly known to western investors as a gaming platform. In fact, NetEase falls into all of the major categories of web revenue generation with significant ad sales, a home page service similar to Yahoo, email, search and a new online B2C (business to consumer) shopping presence. Continue reading NetEase (NTES): China’s Expanding Internet NetEase (NTES): China’s Expanding Internet originally appeared on BloggingStocks on Tue, 08 Feb 2011 13:00:00 EST. Please see our terms for use of feeds . Permalink  |  Email this  |  Comments

Continue Reading »

All That Jazz (JAZZ): Biotech Targets Narcolepsy, OCD and Anxiety

Filed in Bank Gold, EPS, o, revenue, target by on February 8, 2011 0 Comments
All That Jazz (JAZZ): Biotech Targets Narcolepsy, OCD and Anxiety

Filed under: Newsletters , Stocks to Buy “The visible growth story at Jazz Pharmaceuticals ( JAZZ ) is the narcolepsy treatment Xyrem, which accounts for 85% of revenues,” says growth stock specialist Mike Cintolo . The editor of Cabot Top Ten Weekly Report explains, “But Jazz has great potential to make big money with other drugs too-all of which focus on the chemistry of the brain. “Thanks to patents, Jazz has a decade to run with Xyrem before generic competitors can enter the market. Meanwhile, its drugs have potential to treat and/or cure obsessive-compulsive disorders, anxiety disorders, fibromyalgia, epilepsy and restless leg syndrome. Continue reading All That Jazz (JAZZ): Biotech Targets Narcolepsy, OCD and Anxiety All That Jazz (JAZZ): Biotech Targets Narcolepsy, OCD and Anxiety originally appeared on BloggingStocks on Tue, 08 Feb 2011 11:00:00 EST. Please see our terms for use of feeds . Permalink  |  Email this  |  Comments

Continue Reading »

LDK Solar (LDK): ‘One Stop Shop’

Filed in Bank Gold, commodities, o by on February 7, 2011 0 Comments
LDK Solar (LDK): ‘One Stop Shop’

Filed under: International Markets , Newsletters , Commodities , Oil , Stocks to Buy , Green Stocks “The trick within the solar sector is to home in on the stock within the group that has the best shot at putting on a great show,” says Paul Goodwin . The editor of Cabot China & Emerging Markets Report explains, “And we think that stock is LDK Solar ( LDK ), a company that is displaying and forecasting some of the most dynamic growth of any company we follow — solar or not. “LDK Solar got its start in 2005 and came public during the glory days of 2007-the stock nearly tripled from its IPO in June to its top that fall. The company’s claim to fame was its polysilicon and ingots, two of the base supplies needed to make most solar cells and modules. Continue reading LDK Solar (LDK): ‘One Stop Shop’ LDK Solar (LDK): ‘One Stop Shop’ originally appeared on BloggingStocks on Mon, 07 Feb 2011 13:10:00 EST. Please see our terms for use of feeds . Permalink  |  Email this  |  Comments

Continue Reading »

Maxwell Technologies (MXWL): Bet on Better Batteries

Filed in Bank Gold, commodities, lead, o by on January 25, 2011 0 Comments
Maxwell Technologies (MXWL): Bet on Better Batteries

Filed under: Newsletters , Commodities , Oil , Stocks to Buy , Green Stocks “Ultracapacitors are lighter and more powerful than batteries, 10 times more powerful by size as well as 10 times lighter,” notes Brendan Coffey . The editor of Cabot Green Investor explains, “Within this market, Maxwell Technologies ( MXWL ) is a San Diego-based company whose patent-protected ultracapacitors are denser — and therefore able to hold more energy — than those of its competitors. “In a simplified comparison of how powerful and quick Maxwell’s ultracaps are, a lead acid battery takes 10 hours to fully charge. A lithium ion battery will charge in about an hour. Continue reading Maxwell Technologies (MXWL): Bet on Better Batteries Maxwell Technologies (MXWL): Bet on Better Batteries originally appeared on BloggingStocks on Tue, 25 Jan 2011 10:30:00 EST. Please see our terms for use of feeds . Permalink  |  Email this  |  Comments

Continue Reading »

Hot Hands: A One-Fund Strategy for 2011

Filed in Bank Gold, o by on January 24, 2011 0 Comments
Hot Hands: A One-Fund Strategy for 2011

Filed under: Newsletters , Mutual Funds “Our annual ‘Hot Hands’ feature is a simple strategy: buy whichever fund has performed best in the previous year and hold onto it throughout the upcoming one,” says fund expert Jim Lowell . The editor of Fidelity Investor explains, “Over the long haul this strategy has delivered hedge fund-like gains without any of the hedge fund snafus. “Buying the Hot Hands fund doesn’t guarantee you are going to beat the index every year. That’s worth repeating; this strategy has not beaten the market every year. Continue reading Hot Hands: A One-Fund Strategy for 2011 Hot Hands: A One-Fund Strategy for 2011 originally appeared on BloggingStocks on Mon, 24 Jan 2011 13:00:00 EST. Please see our terms for use of feeds . Permalink  |  Email this  |  Comments

Continue Reading »

General Motors (GM): Old Company, New Stock

Filed in Bank Gold, earnings, General Motors, o, revenue by on January 21, 2011 0 Comments
General Motors (GM): Old Company, New Stock

Filed under: General Motors (GM) , Newsletters , Stocks to Buy “We have a bent towards growth companies, with new products or services that are producing major sales and earnings growth; nevertheless, we’re also students of the market, and we believe that the recent ‘re-IPO’ at General Motors ( GM ) provides a big opportunity for investors,” says Mike Cintolo . The editor of Cabot Market Letter explains, “Granted, we’re not going to predict that the stock is going to triple or quadruple; we’re talking about a company with well over $100 billion in annual revenue. Continue reading General Motors (GM): Old Company, New Stock General Motors (GM): Old Company, New Stock originally appeared on BloggingStocks on Fri, 21 Jan 2011 12:30:00 EST. Please see our terms for use of feeds . Permalink  |  Email this  |  Comments

Continue Reading »